With heart disorders affecting individuals globally and contributing to increasing mortality rates, there has been a need to develop new treatment options. One of the specific challenges in the field of tissue engineering is to produce blood vessels within heart muscle tissue. In this study, the researchers were successful in this task. Their live models showed significant improvement in heart function, particularly in the amount of vascularization throughout the implanted sections. Further, the tissue engineered construct remained viable even after the three-week implantation period, maintaining cardiac specific function.
"The long-term goal of cardiac tissue engineering is to generate functional cardiac muscle in vitro," states lead researcher, Ravi K. Birla. "Work in this area would lead to the formation of functional heart muscle that can someday help patients with acute heart failure."
Tissue-engineered heart muscle can be used to treat cases of myocardial infarction and to repair congenital heart defects, as well as in the use of drug development to provide insight into cardiac developmental biology.
This study is published in Artificial Organs. Media who would like to receive a PDF of this paper should contact firstname.lastname@example.org.
The work was conducted by researchers at the University of Michigan as a joint initiative between Ravi K. Birla Ph.D., Gregory H. Borschel MD and Robert G. Dennis Ph.D. Corresponding study author Ravi K. Birla, Ph.D. of the Section of Cardiac Surgery at the University of Michigan currently conducts research focused towards the development of new technologies for cardiovascular tissue engineering with the ultimate goal of tissue replacement in a clinical setting. He can be reached for questions and interviews at (734) 936-2144 or email@example.com.
About the Journal
Since 1977, Artificial Organs has been publishing original articles featuring the studies of design, performance, and evaluation of the biomaterials and devices for the international medical, scientific, and engineering communities involved in the research and clinical application of artificial organ development. Artificial Organs, published monthly, brings its readership the depth and breadth of the science and technology that continues to advance the replacement, recovery and regeneration of organ systems.
About Blackwell Publishing
Blackwell Publishing is the world's leading society publisher, partnering with more than 665 academic, medical, and professional societies. Blackwell publishes over 800 journals and, to date, has published close to 6,000 text and reference books, across a wide range of academic, medical, and professional subjects.